Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure

NCT06571942 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

128

Enrollment

OTHER_GOV

Sponsor class

Conditions

COPD Bronchitis
Pollution Related Respiratory Disorder

Interventions

DRUG: Vilanterol / Umeclidinium (25/62.5 mcg)
DRUG: Fluthicasone / Vilanterol / Umeclidinium (100/25/62.5 mcg)
DRUG: Beclomethasone / Formoterol / Glycopyrronyum 100/6/12.5 mcg
DRUG: Budesonide / Formoterol / Glycopyrronyum 160/4.8/7.2 mcg

Sponsor

National Institute of Respiratory Diseases, Mexico